Verstandig Grant 4
4 · NexImmune, Inc. · Filed Mar 28, 2022
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Verstandig Grant
Director
Transactions
- Purchase
Common Stock
2022-03-25$4.14/sh+131,622$544,915→ 886,512 total - Purchase
Common Stock
2022-03-24$3.35/sh+39,995$133,983→ 754,890 total - Purchase
Common Stock
2022-03-28$3.76/sh+18,983$71,376→ 905,495 total
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.02 to $3.50, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.56 to $4.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.57 to $3.98, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.